Suppr超能文献

光动力疗法治疗胆管癌。

Photodynamic therapy of cholangiocarcinoma.

机构信息

Department of Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany.

出版信息

HPB (Oxford). 2008;10(3):161-3. doi: 10.1080/13651820801992625.

Abstract

Photodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photosensitizing agent in combination with laser irradiation of a distinct wavelength. In some case reports and small non-randomized pilot studies, PDT has proved feasible in patients with hilar bile duct cancer. Those studies showed an astonishing long survival time of the treated patients. In the yet published two randomized controlled studies, PDT showed a significant extension of survival compared to sole bile duct stenting. A possible explanation for this improved survival is a suspected anti-tumor immunological effect induced by PDT. PDT reaches the same level of survival time as incomplete resection. The main complication is a high risk of severe bacterial cholangitis and liver abscesses requiring peri-interventional antibiotics. Skin phototoxicity, which at the beginning of PDT was the most dreaded potential complication, seems to play an ancillary role using mild light protection. As the available photosensitizers, mainly hematoporphyrin derivative (HPD), are not very effective in terms of depth of tumor necrosis, newer photosensitizers with light absorption in the near infrared spectrum and therefore deeper penetration depth are currently under investigation.

摘要

光动力疗法(PDT)是一种局部光化学反应肿瘤治疗方法,由光敏剂与特定波长的激光照射相结合。在一些病例报告和小型非随机试验研究中,PDT 已被证明对肝门部胆管癌患者可行。这些研究显示,接受治疗的患者的生存时间惊人地延长。在已发表的两项随机对照研究中,与单纯胆管支架置入相比,PDT 显示出显著延长的生存时间。这种生存改善的可能解释是 PDT 诱导的抗肿瘤免疫效应。PDT 达到与不完全切除相同的生存时间。主要并发症是严重细菌性胆管炎和肝脓肿的风险很高,需要介入治疗期间使用抗生素。皮肤光毒性,在 PDT 开始时是最令人恐惧的潜在并发症,似乎在使用轻度光保护时起辅助作用。由于现有的光敏剂,主要是血卟啉衍生物(HPD),在肿瘤坏死的深度方面效果不是很好,因此目前正在研究具有近红外光谱吸收和因此具有更深穿透深度的新型光敏剂。

相似文献

1
Photodynamic therapy of cholangiocarcinoma.
HPB (Oxford). 2008;10(3):161-3. doi: 10.1080/13651820801992625.
2
The role of photodynamic therapy for hilar cholangiocarcinoma.
Korean J Intern Med. 2010 Dec;25(4):345-52. doi: 10.3904/kjim.2010.25.4.345. Epub 2010 Nov 27.
3
Current status of photodynamic therapy for bile duct cancer.
Clin Endosc. 2013 Jan;46(1):38-44. doi: 10.5946/ce.2013.46.1.38. Epub 2013 Jan 31.
7
Photodynamic therapy and Klatskin tumour: an overview.
Scand J Gastroenterol Suppl. 2006(243):135-8. doi: 10.1080/00365520600664441.
8
Technology insight: Photodynamic therapy for cholangiocarcinoma.
Nat Clin Pract Gastroenterol Hepatol. 2006 Aug;3(8):459-67. doi: 10.1038/ncpgasthep0543.
9
Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Clin Gastroenterol Hepatol. 2008 Mar;6(3):290-7. doi: 10.1016/j.cgh.2007.12.004. Epub 2008 Feb 6.
10
[History of photodynamic therapy--past, present and future].
Gan To Kagaku Ryoho. 1996 Jan;23(1):8-15.

引用本文的文献

1
Endoscopic Ablation in Cholangiocarcinoma.
Cancers (Basel). 2025 Aug 29;17(17):2843. doi: 10.3390/cancers17172843.
2
Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review.
World J Gastrointest Endosc. 2023 Mar 16;15(3):177-190. doi: 10.4253/wjge.v15.i3.177.
3
Endoscopic management of benign and malignant hilar stricture.
Dig Endosc. 2023 May;35(4):443-452. doi: 10.1111/den.14487. Epub 2023 Jan 10.
5
Intraductal radiofrequency ablation for management of malignant biliary obstruction.
Dig Dis Sci. 2014 Nov;59(11):2635-41. doi: 10.1007/s10620-014-3237-9. Epub 2014 Jun 7.
6
Photodynamic therapy in unresectable cholangiocarcinoma: not for the uncommitted.
Clin Endosc. 2013 Jul;46(4):390-4. doi: 10.5946/ce.2013.46.4.390. Epub 2013 Jul 31.
7
Cholangiocarcinoma treatment.
Curr Gastroenterol Rep. 2012 Dec;14(6):528-33. doi: 10.1007/s11894-012-0286-0.
8
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.
Aliment Pharmacol Ther. 2011 Nov;34(9):1063-78. doi: 10.1111/j.1365-2036.2011.04851.x. Epub 2011 Sep 20.
9
New insights on cholangiocarcinoma.
World J Gastrointest Oncol. 2010 Mar 15;2(3):136-45. doi: 10.4251/wjgo.v2.i3.136.
10
Photodynamic therapy for cholangiocarcinoma.
Gut Liver. 2010 Sep;4 Suppl 1(Suppl 1):S62-6. doi: 10.5009/gnl.2010.4.S1.S62. Epub 2010 Sep 10.

本文引用的文献

2
Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin.
Eur J Gastroenterol Hepatol. 2007 Jun;19(6):479-85. doi: 10.1097/MEG.0b013e328013c0bd.
4
Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.
Am J Gastroenterol. 2005 Nov;100(11):2426-30. doi: 10.1111/j.1572-0241.2005.00318.x.
7
Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.
J Gastroenterol Hepatol. 2005 Mar;20(3):415-20. doi: 10.1111/j.1440-1746.2005.03582.x.
8
Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
J Gastroenterol. 2004 Nov;39(11):1095-101. doi: 10.1007/s00535-004-1449-z.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验